The recombinant zoster vaccine Shingrix is linked to a higher risk of recurrence of herpes zoster ophthalmicus in patients with a history of HZO.
All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.